BioPharmaStock
HomeAsk About StockNewsIdeasHistoryFDA DesignationsElite Program

ADGM

No price yet

Announcements

Nothing here yet

Daily updates

Nothing here yet

FDA designations

Nothing here yet

News

  • Adagio Medical highlighted treatment of the first patient in an IDE study evaluating its next-generation vCLAS Ultra system for ventricular tachycardiaSep 16, 2026
  • Adagio Medical treated the first patient with its next-generation ULTA single-freeze systemAug 3, 2026
  • Adagio Medical submits FDA premarket approval application for vCLAS ventricular ablation systemMay 21, 2026
  • Adagio Medical received FDA IDE approval to study its next-generation ventricular ablation systemApr 8, 2026
  • Adagio Medical announces completion of enrollment for FULCRUM-VT pivotal clinical trial evaluating ultra-low temperature cryoablation for ventricular tachycardiaOct 1, 2025

    Bio Pharma Stock

    Where Science Meets Investing.

    BioPharmaStock is a specialized biopharmaceutical investment intelligence company focused exclusively on publicly traded biotechnology and pharmaceutical companies. Our research team continuously analyzes clinical trials, FDA regulatory events, scientific publications, corporate developments, and market catalysts to deliver timely research and exclusive insights for investors seeking opportunities in one of the world's most knowledge-intensive sectors.

    ALNJAM ALAALI SOFTWARE DESIGN CO. L.L.C, UAE, Abu Dhabi

    BioPharmaStock LogoBioPharmaStock Logo

    Quick Links

    • Home
    • Ask About Stock
    • News
    • Ideas
    • History
    • FDA Designations
    • Elite Program

    Contact Us

    Email: info@biopharmastock.com

    Phone: +971 50 936 3328

    Join Our Community→

    Follow Us

    Get the App

    Instant notifications on your phone

    Download on theApp StoreGet it onGoogle Play

    © 2026 Bio Pharma Stock. All rights reserved. Policy